Novitium Pharma emite retiro del mercado nacional voluntario de las Cápsulas de Clorhidrato de Ranitidina de 150mg y 300mg debido a una cantidad elevada de impureza inesperada, N-Nitrosodimetilamina (NDMA)
October 26, 2019 15:42 ET
|
Novitium Pharma, LLC
EAST WINDSOR, Nueva Jersey, Oct. 26, 2019 (GLOBE NEWSWIRE) -- Novitium Pharma LLC (Novitium) hace un retiro del mercado voluntario de cantidades y lotes, dentro del vencimiento, de las cápsulas de...
Novitium Pharma Issues Voluntary National Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
October 25, 2019 15:17 ET
|
Novitium Pharma, LLC
EAST WINDSOR, N.J., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Novitium Pharma LLC (Novitium) is voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules in the US...
Novitium Pharma Launches Generic Revatio® for Oral Suspension, 10mg/mL
June 04, 2019 12:00 ET
|
Novitium Pharma, LLC
EAST WINDSOR, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Novitium Pharma LLC has received the Food and Drug Administration’s clearance for Sildenafil for Oral Suspension, 10mg/mL. The product is the...
Novitium Pharma Launches Thiothixene Capsules USP 1mg, 2mg, 5mg, 10mg
April 16, 2019 12:00 ET
|
Novitium Pharma, LLC
EAST WINDSOR, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Novitium Pharma LLC is pleased to announce that it has received U.S. Food and Drug Administration approval of its Abbreviated New Drug...
Novitium Pharma Launches Ranitidine Capsules
November 28, 2018 12:00 ET
|
Novitium Pharma, LLC
EAST WINDSOR, N.J., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Novitium Pharma LLC is pleased to announce that it has received U.S. Food and Drug Administration approval on its Abbreviated New Drug...
Novitium Pharma Launches Prazosin Hydrochloride Capsules USP
October 08, 2018 12:00 ET
|
Novitium Pharma, LLC
EAST WINDSOR, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Novitium Pharma LLC today announced that it has received U.S. Food and Drug Administration approval on its Abbreviated New Drug Application...